Skip to main content
. Author manuscript; available in PMC: 2009 Sep 27.
Published in final edited form as: J Pharm Pharmacol. 2008 Aug;60(8):1049–1060. doi: 10.1211/jpp.60.8.0011

Figure 8.

Figure 8

A) Salivary gland production for fractionated radiation treatment with and without Tempol administration. B) Radiation tumor (SCCVII) regrowth study for local fractionated radiation treatment with and without Tempol administration. Tumors received 5 daily fractions (Monday-Friday) of 3 Gy (SCC VII) or 2 Gy (HT-29). Arrows on each plot indicate the days when radiation treatment was administered. (Adapted with permission from (Cotrim et al 2007))